510 related articles for article (PubMed ID: 3404441)
21. Cardiac inotropic as well as coronary and pulmonary artery actions of epinine in human isolated tissues.
Schwinger RH; Böhm M; Schulz C; Schmidt U; Schmidt U; Schmid B; Dienemann H; Reichart B; Erdmann E
J Pharmacol Exp Ther; 1993 Apr; 265(1):346-57. PubMed ID: 8386240
[TBL] [Abstract][Full Text] [Related]
22. Dopamine effects on circulation and myocardial oxygen supply.
Brückner JB; Hess W; Schmidt D; Schneider E; Schweichel E
Proc R Soc Med; 1977; 70 Suppl 2(Suppl 2):43-7. PubMed ID: 264201
[TBL] [Abstract][Full Text] [Related]
23. Myocardial blood flow and oxygen consumption during isovolemic hemodilution alone and in combination with adenosine-induced controlled hypotension.
Crystal GJ; Rooney MW; Salem MR
Anesth Analg; 1988 Jun; 67(6):539-47. PubMed ID: 3377208
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the cardiovascular actions of dopamine and epinine in the dog.
Itoh H; Kohli JD; Rajfer SI; Goldberg LI
J Pharmacol Exp Ther; 1985 Apr; 233(1):87-93. PubMed ID: 2858584
[TBL] [Abstract][Full Text] [Related]
25. Cerebral circulatory and cardiac effects of vinpocetine and its metabolite, apovincaminic acid, in anesthetized dogs.
Imamoto T; Tanabe M; Shimamoto N; Kawazoe K; Hirata M
Arzneimittelforschung; 1984; 34(2):161-9. PubMed ID: 6539108
[TBL] [Abstract][Full Text] [Related]
26. Acute haemodynamic effects of ibopamine and dopamine on isovolumic relaxation.
Bernardi L; Perlini S; Soffiantino F; Farilla C; Calciati A; Soldá PL; Paro M; Merlo L; Marchetti G; Finardi G
Eur J Pharmacol; 1989 May; 164(3):415-24. PubMed ID: 2767116
[TBL] [Abstract][Full Text] [Related]
27. Effects of morphine on coronary and left ventricular dynamics in conscious dogs.
Vatner SF; Marsh JD; Swain JA
J Clin Invest; 1975 Feb; 55(2):207-17. PubMed ID: 236324
[TBL] [Abstract][Full Text] [Related]
28. [Alpha-adrenergic control of coronary circulation and left ventricular function during exertion].
Heyndrickx GR; Pannier JL
Verh K Acad Geneeskd Belg; 1990; 52(3):225-91. PubMed ID: 1977244
[TBL] [Abstract][Full Text] [Related]
29. Effects of ibopamine on peripheral hemodynamics: a strain gauge plethysmographic study in patients with congestive heart failure.
Musacci GF; Ansani L; Toselli T; Aggio S; Baracca E; Longhini C
Arzneimittelforschung; 1986 Feb; 36(2A):380-2. PubMed ID: 3707654
[TBL] [Abstract][Full Text] [Related]
30. Coronary thrombolysis with intravenous streptokinase in the anesthetized dog: a dose-response study.
Kopia GA; Kopaciewicz LJ; Ruffolo RR
J Pharmacol Exp Ther; 1988 Mar; 244(3):956-62. PubMed ID: 3252043
[TBL] [Abstract][Full Text] [Related]
31. [The energetics and economics of the cardiac pump function].
Hoeft A; Korb H; Hellige G; Sonntag H; Kettler D
Anaesthesist; 1991 Sep; 40(9):465-78. PubMed ID: 1952041
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
Dei Cas L; Metra M; Nodari S; Visioli O
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S111-7. PubMed ID: 2483436
[TBL] [Abstract][Full Text] [Related]
33. Effect of dopamine, ibopamine, and epinine on alpha- and beta-adrenoceptors in canine pulmonary circulation.
Shebuski RJ; Smith JM; Ruffolo R
Fundam Clin Pharmacol; 1989; 3(3):211-21. PubMed ID: 2548941
[TBL] [Abstract][Full Text] [Related]
34. [A comparison of cardiovascular effects of dobutamine and dopamine (author's transl)].
Hess W; Brückner JB; Schmidt D; Schweichel E; Tarnow J
Z Kardiol; 1977 Oct; 66(10):537-44. PubMed ID: 919662
[TBL] [Abstract][Full Text] [Related]
35. Cardiac electrophysiologic and hemodynamic activity of pimobendan (UD-CG 115 BS), a new inotropic agent.
Kitzen JM; Lynch JJ; Driscoll EM; Lucchesi BR
J Pharmacol Exp Ther; 1988 Mar; 244(3):929-39. PubMed ID: 3252039
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs.
Damiano BP; Giardino EC; Haertlein BJ; Stump GL; Mitchell JA; Falotico R
J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological studies of a newly synthetized 1,4-dihydropyridine derivative, 2,6-dimethyl-3,5-dimethoxycarbonyl-4- (o-difluoromethoxyphenyl)-1,4-dihydropyridine (PP-1466).
Toribatake T; Fujii K; Kobayashi M; Okumura M; Aikawa K
Arzneimittelforschung; 1985; 35(4):680-6. PubMed ID: 4015734
[TBL] [Abstract][Full Text] [Related]
38. Relation between myocardial beta-adrenoceptor density and hemodynamic and neurohumoral changes in a rat model of chronic myocardial infarction: effects of ibopamine and captopril.
van Veldhuisen DJ; Brodde OE; van Gilst WH; Schulze C; Hegeman H; Anthonio RL; Scholtens E; de Graeff PA; Wesseling H; Lie KI
Cardiovasc Res; 1995 Sep; 30(3):386-93. PubMed ID: 7585830
[TBL] [Abstract][Full Text] [Related]
39. Effect of MCI-154, a cardiotonic agent, on regional contractile function and myocardial oxygen consumption in the presence and absence of coronary artery stenosis in dogs.
Abe Y; Kitada Y; Narimatsu A
J Pharmacol Exp Ther; 1993 May; 265(2):819-25. PubMed ID: 8496827
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular effects of KRN2391 in anesthetized dogs: a comparison with cromakalim and nitroglycerin.
Kaneta S; Yokoyama T; Izumi H; Izawa T; Ogawa N
Arch Int Pharmacodyn Ther; 1994; 327(2):184-93. PubMed ID: 7979827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
